Given over three- to five-minutes, Opdivo Qvantig demonstrated consistent efficacy and showed a comparable safety profile to intravenous Opdivo in the Phase 3 CheckMate-67T trial 1,3 Opdivo and Opdivo ...
Please provide your email address to receive an email when new articles are posted on . Opdivo was previously only available intravenously. The approval comes after CHECKMATE-67T study results. Opdivo ...
Huonslab said Wednesday that Hydizyme, its self-developed recombinant human hyaluronidase injection, is expected to be approved in the second half of this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results